Hospital Miguel Servet -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2024

  1. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  2. Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor

    European Journal of Cancer, Vol. 209

2023

  1. Corrigendum to ‘Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study’ [Eur J Cancer 171 (2022) 183–192, (S0959804922002696), (10.1016/j.ejca.2022.04.030)]

    European Journal of Cancer

2022

  1. Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study

    European Journal of Cancer, Vol. 171, pp. 183-192

2021

  1. A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin

    Molecular Oncology, Vol. 15, Núm. 12, pp. 3691-3705

  2. Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS – GROUP). Part I

    Cancer Treatment Reviews, Vol. 99

  3. Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS –GROUP). Part II

    Cancer Treatment Reviews, Vol. 99